MedTrace Logo

The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver

NCT01785212 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-04-07

No results posted yet for this study

Summary

The CUSA (cavitron ultrasound surgical aspirator) is the method of choice for hepatic resection in our center. Recently a stapler-hepatectomy methods has been developed and approved for liver surgery using Covidien Endo-Gia stapler. The potential benefit of this method is a potential shorter transection time compared to the CUSA technique. Thus the investigators will perform a randomized controlled trial including 20 patients in the stapler-group and 20 patients in the CUSA control group. Primary endpoint will be transection speed. Secondary endpoints will be peri-operative (d-1, d0, d1, d3) cytokines concentration, T cell subsets, blood loss, morbidity, and a cost analysis.

Conditions

  • Liver Neoplasms
  • Liver Metastasis
  • Liver Hemangioma
  • Echinococcosis, Hepatic

Interventions

DEVICE

Stapler

stapler hepatectomy

DEVICE

CUSA (Cavitron ultrasonic aspirator; Valleylab, Boulder, CO)

CUSA is a well established device used for hepatic resection using ultrasound

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Klaus Kaczirek, M.D. · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-12-31
Completion
2015-04-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01785212 on ClinicalTrials.gov